These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 883399)

  • 21. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 22. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M; Husz S; Dobozy A
    Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contribution to the study of serum immunoglobulins. Preliminary research in rheumatoid arthritis, erythematovisceritis and scleroderma].
    Loni C; Ambrogi F; Tomei GP
    G Clin Med; 1966 Oct; 47(10):927-33. PubMed ID: 4172840
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cryoglobulinemia in reactive mesenchymopathies].
    Dammacco F; Schena FP; Bonomo L
    Reumatismo; 1967; 19(5):312-6. PubMed ID: 4184774
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of leukocyte and platelet antibodies in systemic lupus erythematosus and related syndromes].
    Mayer S; Souissi T; Tongio MM; Berrebi A
    Nouv Rev Fr Hematol; 1971; 11(5):701-16. PubMed ID: 4114387
    [No Abstract]   [Full Text] [Related]  

  • 27. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 28. [Collagen disease from the aspect of dermatology with special reference to overlapping of systemic lupus erythematosus, progressive sclerosis and dermatomyositis].
    Nishiyama S; Nishiwaki M; Ono K; Ushijima T
    Saishin Igaku; 1969 Oct; 24(10):2036-47. PubMed ID: 5349227
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
    Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
    Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Autoimmune changes in various rheumatic diseases].
    Borisova AM
    Ter Arkh; 1986; 58(7):43-6. PubMed ID: 3490009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphocyte transformation in autoimmune skin diseases].
    Mészáros C; Nagy E
    Z Haut Geschlechtskr; 1969 Apr; 44(8):265-8. PubMed ID: 4188257
    [No Abstract]   [Full Text] [Related]  

  • 33. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses.
    Homberg JC; Rizzetto M; Doniach D
    Clin Exp Immunol; 1974 Aug; 17(4):617-28. PubMed ID: 4466618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of cutaneous lupus erythematosus by immunohistochemical methods.
    Pohle EL; Tuffanelli DL
    Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 36. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
    Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG
    Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-nucleic acid antibodies in children with systemic lupus erythematosus and systemic scleroderma and in their relatives living with the probands].
    Adamashvili IM; Makarova OV; Zamchuk LA; Gvardzhaladze TV
    Revmatologiia (Mosk); 1991; (4):13-6. PubMed ID: 1725222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports.
    Al Attia HM; D'Souza MS
    Clin Rheumatol; 2003 Feb; 22(1):70-2. PubMed ID: 12605324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of immunological processes in expert testimony regarding disability in rheumatologic diseases].
    Morozova RZ; Pentiuk AA
    Vrach Delo; 1980 Mar; (3):58-60. PubMed ID: 7376615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.